GEHC logo

GE HealthCare Technologies Inc. (GEHC)

$81.84

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on GEHC

Market cap

$37.00B

EPS

4.73

P/E ratio

15.1

Price to sales

1.4

Dividend yield

0.196%

Beta

0.76761

Price on GEHC

Previous close

$82.96

Today's open

$82.49

Day's range

$81.79 - $83.65

52 week range

$58.75 - $89.77

Profile about GEHC

CEO

Peter J. Arduini

Employees

54000

Headquarters

Chicago, IL

Exchange

Nasdaq Global Select

Shares outstanding

452137831

Issue type

Common Stock

GEHC industries and sectors

Healthcare

Medical Diagnostics & Screening

News on GEHC

GE HealthCare Expands Global Research Network for Photon-Counting CT

GEHC expands its global research network for Photonova Spectra to advance photon-counting CT applications, clinical adoption and diagnostic capabilities.

news source

Zacks Investment Research • 6 hours ago

news preview

GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the integration of the AW ONE ecosystem, a unified ecosystem for post processing and advanced visualization, with InteleViewer, IntelePACS' diagnostic viewer designed to support seamless radiology workflows.1 Clinicians can now launch advanced visualization and workflow automation applications in the AW ONE ecosystem directly within InteleViewer as they review and interpret images, without having to switch to a separate environmen.

news source

Business Wire • 11 hours ago

news preview

Here's Why You Should Add GEHC Stock to Your Portfolio Right Now

GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks.

news source

Zacks Investment Research • Nov 17, 2026

news preview

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals and research institutions across North America, Europe and Asia are beginning structured evaluations of Photonova Spectra to further define its clinical utility, optimize imaging protocols and explore n.

news source

Business Wire • Nov 16, 2026

news preview

GEHC or SYK: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

news source

Zacks Investment Research • Nov 16, 2026

news preview

GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research

GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions.

news source

Zacks Investment Research • Nov 13, 2026

news preview

GE HealthCare: 3 Key Takeaways for Long-Term Investors

GE HealthCare raised its full-year 2026 organic revenue guidance to 4%. The equipment backlog grew 12% year over year to $23.7 billion.

news source

The Motley Fool • Nov 11, 2026

news preview

GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 10, 2026

news preview

GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS

GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support.

news source

Zacks Investment Research • Nov 10, 2026

news preview

GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the intent to establish a collaborative research network focused on advancing neuroscience research leveraging an ultra high-gradient head-only 3.0T MR system1. The MAGNUS2 Neuro Alliance will bring together researchers and clinicians with expertise in neurology, radiology, psychiatry, oncology, and several other subject areas, to explore how high-performance MR imaging may enable new scientific questions and research approa.

news source

Business Wire • Nov 10, 2026

news preview

¹ Disclosures

Get started with M1

Invest in GE HealthCare Technologies Inc.

Open an M1 investment account to buy and sell GE HealthCare Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in GEHC on M1